Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
April 5, 2013
The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option
Mahendra Kashyap, Pradeep Tyagi
Expert Opinion on Drug Delivery
|
October 20, 2015
Advances in intravesical therapy for urinary tract disorders
Pradeep Tyagi, Mahendra Kashyap, Harvey Hensley, et al.
Life Sciences
|
February 9, 2016
Constitutive expression Of NGF And P75(NTR) affected by bladder distension and NGF antisense treatment
Mahendra Kashyap, Subrata Pore, Naoki Yoshimura, et al.
Expert Opinion on Investigational Drugs
|
March 5, 2016
Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC)
Yao-Chi Chuang, Christopher Chermansky, Mahendra Kashyap, et al.
Life Sciences
|
October 30, 2016
Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factor
Mahendra Kashyap, Subrata Pore, Michael Chancellor, et al.
Neurourology and Urodynamics
|
May 12, 2017
MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin-A injection
Christopher J Chermansky, Brian T Kadow, Mahendra Kashyap, et al.
American Journal of Clinical and Experimental Urology
|
November 25, 2020
Constitutively active HCN channels constrain detrusor excitability and modulate evoked contractions of human bladder
Mahendra Kashyap, Nishant Singh, Naoki Yoshimura, et al.
Urology
|
November 3, 2015
Spontaneous Recovery of Reflex Voiding Following Spinal Cord Injury Mediated by Anti-inflammatory and Neuroprotective Factors
Pradeep Tyagi, Katsumi Kadekawa, Mahendra Kashyap, et al.
Bladder (San Francisco, Calif.)
|
December 29, 2015
Characterization of the role of HCN channels in β3-adrenoceptor mediated rat bladder relaxation
Mahendra Kashyap, Naoki Yoshimura, Phillip P Smith, et al.
The Journal of Urology
|
November 23, 2016
Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder
Pradeep Tyagi, Mahendra Kashyap, Naoki Yoshimura, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Expert Opinion on Drug Metabolism & Toxicology
|
April 5, 2013
The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option
Mahendra Kashyap, Pradeep Tyagi
Expert Opinion on Drug Delivery
|
October 20, 2015
Advances in intravesical therapy for urinary tract disorders
Pradeep Tyagi, Mahendra Kashyap, Harvey Hensley, et al.
Life Sciences
|
February 9, 2016
Constitutive expression Of NGF And P75(NTR) affected by bladder distension and NGF antisense treatment
Mahendra Kashyap, Subrata Pore, Naoki Yoshimura, et al.
Expert Opinion on Investigational Drugs
|
March 5, 2016
Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC)
Yao-Chi Chuang, Christopher Chermansky, Mahendra Kashyap, et al.
Life Sciences
|
October 30, 2016
Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factor
Mahendra Kashyap, Subrata Pore, Michael Chancellor, et al.
Neurourology and Urodynamics
|
May 12, 2017
MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin-A injection
Christopher J Chermansky, Brian T Kadow, Mahendra Kashyap, et al.
American Journal of Clinical and Experimental Urology
|
November 25, 2020
Constitutively active HCN channels constrain detrusor excitability and modulate evoked contractions of human bladder
Mahendra Kashyap, Nishant Singh, Naoki Yoshimura, et al.
Urology
|
November 3, 2015
Spontaneous Recovery of Reflex Voiding Following Spinal Cord Injury Mediated by Anti-inflammatory and Neuroprotective Factors
Pradeep Tyagi, Katsumi Kadekawa, Mahendra Kashyap, et al.
Bladder (San Francisco, Calif.)
|
December 29, 2015
Characterization of the role of HCN channels in β3-adrenoceptor mediated rat bladder relaxation
Mahendra Kashyap, Naoki Yoshimura, Phillip P Smith, et al.
The Journal of Urology
|
November 23, 2016
Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder
Pradeep Tyagi, Mahendra Kashyap, Naoki Yoshimura, et al.
Page
of 3